argus

Thyrocare Technologies Limited

NSE: THYROCAREINE594H010199,446 Cr

Timeline

Time (IST)TypeMEventSrc
17 Jan, 09:36 pmThyrocare Technologies Ltd - 539871 - Change Of Name Of M S K A & Associates Upon Conversion Of Firm Into LLPbse
05 Jan, 11:16 amThyrocare Technologies Limited has informed the Exchange about the Appointment of Mr. Rajdeep Panwar as Chief Commercial Officer of the Company w.e.f. January 05, 2026.nse
05 Jan, 11:14 amThyrocare Technologies Limited has informed the Exchange regarding Appointment of Mr. Rajdeep Panwar as Chief Commercial Officer of the company w.e.f. January 05, 2026.nse
05 Jan, 11:12 amThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Change in Managementbse
18 Dec, 10:47 amThyrocare Technologies Limited has informed the Exchange regarding Appointment of Dr. Ramesh Kinha as Chief Operating Officer of the Company w.e.f. December 18, 2025.nse
18 Dec, 10:45 amThyrocare Technologies Limited has informed the Exchange about the Appointment of Dr. Ramesh Kinha as Chief Operating Officer (COO) of the Company.nse
18 Dec, 10:42 amThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Change in Managementbse
05 Dec, 06:01 pmThyrocare Technologies Ltd - 539871 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.bse
05 Dec, 05:59 pmThyrocare Technologies Ltd - 539871 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
04 Dec, 10:26 amThyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
03 Dec, 10:14 amThyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
01 Dec, 08:53 amThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Allotmentbse
01 Dec, 08:52 amThyrocare Technologies Limited has informed the Exchange regarding allotment of 10,61,07,794 securities pursuant to Bonus at its meeting held on December 01, 2025nse
01 Dec, 08:44 amThyrocare Technologies Limited has informed the Exchange regarding allotment of 10,61,07,794 securities pursuant to Bonus at its meeting held on December 01, 2025nse
01 Dec, 08:42 amThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Allotmentbse
29 Nov, 11:55 amThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Change in Managementbse
29 Nov, 11:45 amThyrocare Technologies Limited has informed the Exchange about Change in Senior Management Personnel of the Companynse
17 Nov, 03:13 pmThis is to inform that an advertisement on Record date for issue of Bonus Equity shares has been published, today, i.e., November 17, 2025 in the following newspapers:(i) Business Standard (English) and (ii) Pratahkal (Marathi). The newspaper clippings are enclosed for information and recordsnse
16 Nov, 11:46 pmThyrocare Technologies Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.nse
16 Nov, 11:44 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Associationbse
16 Nov, 11:42 pmThyrocare Technologies Ltd - 539871 - Corporate Action - Fixes Record Date For Bonus Issuebse
16 Nov, 11:39 pmThyrocare Technologies Limited has informed the Exchange that Record date for the purpose of Bonus is 28-Nov-2025.nse
14 Nov, 02:39 pmThyrocare Technologies Ltd - 539871 - Clarification On Significant Movement In Volume Of Shares Of The Companybse
14 Nov, 01:46 pmThyrocare Technologies Ltd - 539871 - Clarification sought from Thyrocare Technologies Ltdbse
13 Nov, 07:26 pmSignificant increase in volume has been observed in Thyrocare Technologies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Thyrocare Technologies Limited has submitted their response.nse
13 Nov, 06:04 pmSignificant increase in volume has been observed in Thyrocare Technologies Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.nse
12 Nov, 05:10 pmDocon Technologies Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(1) and 31(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
12 Nov, 11:10 amThyrocare Technologies Ltd - 539871 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
28 Oct, 04:34 pmThyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
27 Oct, 06:53 pmThyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011bse
24 Oct, 11:46 amThyrocare Technologies Limited has informed the Exchange about disclosure of Sale of 53,32,860 Equity Shares (approximately 10% Stake) by Promoter - Docon Technologies Private Limitednse
17 Oct, 08:22 pmThyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on October 14, 2025nse
17 Oct, 08:16 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
15 Oct, 04:08 pmThyrocare Technologies Limited has informed the Exchange about Copy of Newspaper Publications for the Unaudited Financial Results for the Quarter and Half Year ended September 30, 2025nse
14 Oct, 09:09 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
14 Oct, 08:53 pmThyrocare Technologies Limited has informed the Exchange about Link of Recordingnse
14 Oct, 05:02 pmThyrocare Technologies Ltd - 539871 - Corporate Action-Board recommends Bonus Issuebse
14 Oct, 05:00 pmThyrocare Technologies Limited has informed the Exchange that the Board of Directors at its meeting held on October 14, 2025, has considered, approved, and recommended to the shareholders the issuance of bonus shares in the ratio of 2:1, i.e., 2 new equity shares for every 1 existing equity share, subject to the approval of the shareholders.nse
14 Oct, 04:58 pmThyrocare Technologies Limited has informed the Exchange that Record date for the purpose of Interim Dividend is 24-Oct-2025.nse
14 Oct, 04:53 pmThyrocare Technologies Ltd - 539871 - Corporate Action-Board approves Dividendbse
14 Oct, 04:53 pmThyrocare Technologies Limited has informed the Exchange that the Board of Directors, at its meeting held on October 14, 2025, declared an interim dividend of Rs. 7 per equity share.nse
14 Oct, 04:49 pmThyrocare Technologies Limited has informed the Exchange regarding the re-appointment of Ernst & Young as the internal auditors of the company.nse
14 Oct, 04:33 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
14 Oct, 04:32 pmThyrocare Technologies Limited has informed the Exchange regarding a press release dated October 14, 2025, titled "Press Release on unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2025, Interim Dividend and proposal for issuance of Bonus Shares.".nse
14 Oct, 04:26 pmThyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
14 Oct, 04:24 pmThyrocare Technologies Limited has informed the Exchange about Investor Presentationnse
14 Oct, 04:19 pmThyrocare Technologies Ltd - 539871 - Financial Results For The Quarter And Half Year Ended September 30, 2025.bse
14 Oct, 04:15 pmThyrocare Technologies Limited has submitted to the Exchange, Outcome of the Board Meeting held on October 14, 2025, for the approval of financial results for the quarter and half year ended September 30, 2025, interim dividend, issuance of bonus shares, and other matters as detailed in the enclosed letter.nse
06 Oct, 05:11 pmThyrocare Technologies Ltd - 539871 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025, Declaration Of Interim Dividend And Proposal For Issue Of Bonus Shares.bse
24 Sept, 06:39 pmThyrocare Technologies Ltd - 539871 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse